Search by Drug Name or NDC
NDC 00003-0371-13 NULOJIX 250 mg/1 Details
NULOJIX 250 mg/1
NULOJIX is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E.R. Squibb & Sons, L.L.C.. The primary component is BELATACEPT.
MedlinePlus Drug Summary
Belatacept injection is used in combination with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) of kidney transplants. Belatacept injection is in a class of medications called immunosuppressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted kidney.
Related Packages: 00003-0371-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Belatacept Injection
Product Information
| NDC | 00003-0371 |
|---|---|
| Product ID | 0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab |
| Associated GPIs | 99408020002120 |
| GCN Sequence Number | 067516 |
| GCN Sequence Number Description | belatacept VIAL 250 MG INTRAVEN |
| HIC3 | Z2E |
| HIC3 Description | IMMUNOSUPPRESSIVES |
| GCN | 30094 |
| HICL Sequence Number | 037705 |
| HICL Sequence Number Description | BELATACEPT |
| Brand/Generic | Brand |
| Proprietary Name | NULOJIX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | BELATACEPT |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | BELATACEPT |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Pharmaceutical Class | CD80-directed Antibody Interactions [MoA], CD86-directed Antibody Interactions [MoA], Selective T Cell Costimulation Blocker [EPC], T Lymphocyte Costimulation Activity Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125288 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00003-0371-13 (00003037113)
| NDC Package Code | 0003-0371-13 |
|---|---|
| Billing NDC | 00003037113 |
| Package | 1 VIAL, SINGLE-USE in 1 CARTON (0003-0371-13) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2011-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |